Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessment of Safety and Efficacy of Gabapentin After Surface Ablation, a Case Control Experimental Study
Sponsor: Research Institute of Ophthalmology, Egypt
Summary
The current study aims at assessing the efficacy and safety of oral Gabapentin alone versus Diclofenac Potassium drugs for postoperative analgesia in patients undergoing surface ablation.
Official title: Assessment of Safety and Efficacy of Gabapentin for Postoperative Analgesia After Surface Ablation, Versus Diclofenac Potassium as a Gold Standard
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
64
Start Date
2024-12-01
Completion Date
2025-06
Last Updated
2025-04-30
Healthy Volunteers
No
Interventions
Giving post photorefractive keratectomy for pain relief
We plan to conduct a randomized prospective study to assess the efficacy and safety of oral Gabapentin versus oral Diclofenac Potassium for postoperative analgesia in adults undergoing surface ablation. The first group will be given gabapentin orally in a dose of 300mg Tid for 72 hours and the second group will be given oral diclofenac potassium 50mg Tid for 72 hours. The drugs will be administered starting from the first day postoperative.
Locations (1)
Research Institute of Ophthalmolgy
Giza, Egypt